Many investors hoping for a resurgence by biotech stocks have hitched their wagons to the Federal Reserve lowering interest rates. That’s a practical bet because biotech is a rate-sensitive industry. But amid concern the central bank won’t be able to cut rates over soon, that bet could be a loser. However, there signs of life [...] The post Biopharma R&D Trends Could Bode Well for This ETF appeared first on ETF Trends .